Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 69-43-2
2. Prenylamine Lactate [jan]
3. 6j3j6sxi7v
4. Angormin
5. Coredamin
6. Corontin
7. Crepasin
8. Incoran
9. Irrorin
10. Plactamin
11. Reocorin
12. Seccidin
13. Sedolatan
14. Agozol
15. Roinin
16. Prenylamine Lactate (jan)
17. 3,3-diphenyl-n-(1-phenylpropan-2-yl)propan-1-amine;2-hydroxypropanoic Acid
18. Einecs 200-705-5
19. Unii-6j3j6sxi7v
20. Segontin (tn)
21. Prestwick_878
22. N-(3,3-diphenylpropyl)-alpha-methylphenethylamine Lactate
23. Dl-prenylamine Lactate
24. Mls002153874
25. Chembl1367944
26. Prenylamine Lactate [mi]
27. Schembl10614915
28. Hms1569p21
29. Hms2233j09
30. Hms3372i12
31. Hms3713p21
32. Phenethylamine, N-(3,3-diphenylpropyl)-alpha-methyl-, Lactate
33. Prenylamine Lactate [mart.]
34. Prenylamine Lactate [who-dd]
35. Ccg-220560
36. Smr001233228
37. D02167
38. Sr-01000838858
39. Sr-01000838858-2
40. Q27264978
41. Benzenepropanamine, N-(1-methyl-2-phenylethyl)-.gamma.-phenyl-, 2-hydroxypropanoate
42. Lactic Acid, Compd. With N-(3,3-diphenylpropyl)-.alpha.-methylphenethylamine (1:1)
43. 2-hydroxypropanoic Acid Compd. With N-(1-methyl-2-phenylethyl)-gamma-phenylbenzenepropanamine (1:1)
44. Propanoic Acid, 2-hydroxy-, Compd. With N-(1-methyl-2-phenylethyl)-.gamma.-phenylbenzenepropanamine (1:1)
| Molecular Weight | 419.6 g/mol |
|---|---|
| Molecular Formula | C27H33NO3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 9 |
| Exact Mass | 419.24604391 g/mol |
| Monoisotopic Mass | 419.24604391 g/mol |
| Topological Polar Surface Area | 69.6 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 375 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Prenylamine Lactate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prenylamine Lactate, including repackagers and relabelers. The FDA regulates Prenylamine Lactate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prenylamine Lactate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Prenylamine Lactate supplier is an individual or a company that provides Prenylamine Lactate active pharmaceutical ingredient (API) or Prenylamine Lactate finished formulations upon request. The Prenylamine Lactate suppliers may include Prenylamine Lactate API manufacturers, exporters, distributors and traders.
click here to find a list of Prenylamine Lactate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Prenylamine Lactate DMF (Drug Master File) is a document detailing the whole manufacturing process of Prenylamine Lactate active pharmaceutical ingredient (API) in detail. Different forms of Prenylamine Lactate DMFs exist exist since differing nations have different regulations, such as Prenylamine Lactate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Prenylamine Lactate DMF submitted to regulatory agencies in the US is known as a USDMF. Prenylamine Lactate USDMF includes data on Prenylamine Lactate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Prenylamine Lactate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Prenylamine Lactate suppliers with USDMF on PharmaCompass.
Prenylamine Lactate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Prenylamine Lactate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prenylamine Lactate GMP manufacturer or Prenylamine Lactate GMP API supplier for your needs.
A Prenylamine Lactate CoA (Certificate of Analysis) is a formal document that attests to Prenylamine Lactate's compliance with Prenylamine Lactate specifications and serves as a tool for batch-level quality control.
Prenylamine Lactate CoA mostly includes findings from lab analyses of a specific batch. For each Prenylamine Lactate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Prenylamine Lactate may be tested according to a variety of international standards, such as European Pharmacopoeia (Prenylamine Lactate EP), Prenylamine Lactate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prenylamine Lactate USP).
LOOKING FOR A SUPPLIER?
